Camargo Pharmaceuticals

Camargo Pharmaceutical Services is a leading global strategic drug development consulting firm and contract research organization (CRO) specializing in the FDA's 505(b)(2) regulatory pathway. Founded in 2003, the company provides end-to-end support for pharmaceutical and biotech companies, including regulatory strategy, clinical trial design, and CMC management. Camargo is widely recognized for its expertise in drug repurposing, orphan drug development, and navigating complex regulatory requirements to accelerate time-to-market. In 2021, the company was acquired by Premier Research, integrating its specialized regulatory capabilities into a broader global clinical development platform.